SCHEDULE 13G/A
Statement of Beneficial Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001213900-26-120155
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 22,287,501 | 9.99% |
| Vivo Opportunity, LLC | 22,287,501 | 9.99% |
| Vivo Opportunity Cayman Fund, L.P. | 2,251,010 | 9.99% |
| Vivo Opportunity Cayman, LLC | 2,251,010 | 9.99% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…